sunitinib,nivolumab,ipilimumab,cabozantinib
bms,pfizer
['#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'renal,(-adrenal)', 'check,mate,9er', 'bms']
#bms stated that checkmate -9er is longest reported follow-up trial of an #immunotherapy-tyrosine kinase inhibitor regimen in patients with advanced renal cell carcinoma. #news #media #gu23 #ascogu23 #asco23 #ascogu2023 #asco #kidneycancer #conferences
#iPharmaCenter is a #website which covers #pharmaceutical and #healthcare #news plus #blogs #diseases #drugs #healthcaresystems #globalhealth #pharma